Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$26.13 - $33.94 $1,567 - $2,036
60 Added 0.86%
7,022 $202,000
Q3 2023

Oct 26, 2023

SELL
$32.09 - $37.51 $22,334 - $26,106
-696 Reduced 9.09%
6,962 $230,000
Q2 2023

Jul 31, 2023

SELL
$36.12 - $41.79 $23,514 - $27,205
-651 Reduced 7.83%
7,658 $280,000
Q1 2023

Apr 20, 2023

BUY
$39.39 - $51.28 $14,219 - $18,512
361 Added 4.54%
8,309 $339,000
Q4 2022

Jan 31, 2023

BUY
$41.75 - $54.5 $4,968 - $6,485
119 Added 1.52%
7,948 $407,000
Q3 2022

Oct 24, 2022

SELL
$43.76 - $53.42 $13,521 - $16,506
-309 Reduced 3.8%
7,829 $343,000
Q2 2022

Jul 28, 2022

BUY
$46.53 - $55.17 $6,793 - $8,054
146 Added 1.83%
8,138 $427,000
Q1 2022

Apr 27, 2022

BUY
$45.75 - $56.69 $5,581 - $6,916
122 Added 1.55%
7,992 $414,000
Q4 2021

Feb 04, 2022

BUY
$41.32 - $61.25 $6,941 - $10,290
168 Added 2.18%
7,870 $465,000
Q3 2021

Oct 18, 2021

SELL
$39.25 - $50.42 $2,276 - $2,924
-58 Reduced 0.75%
7,702 $331,000
Q2 2021

Jul 27, 2021

BUY
$35.91 - $40.68 $7,325 - $8,298
204 Added 2.7%
7,760 $304,000
Q1 2021

May 04, 2021

SELL
$33.49 - $37.77 $368 - $415
-11 Reduced 0.15%
7,556 $274,000
Q4 2020

Feb 03, 2021

BUY
$33.47 - $42.56 $3,849 - $4,894
115 Added 1.54%
7,567 $279,000
Q3 2020

Nov 05, 2020

SELL
$31.75 - $37.25 $730 - $856
-23 Reduced 0.31%
7,452 $273,000
Q2 2020

Jul 30, 2020

BUY
$30.12 - $36.54 $6,686 - $8,111
222 Added 3.06%
7,475 $244,000
Q1 2020

Apr 29, 2020

SELL
$27.03 - $38.62 $49,843 - $71,215
-1,844 Reduced 20.27%
7,253 $237,000
Q4 2019

Jan 31, 2020

BUY
$32.92 - $37.36 $23,175 - $26,301
704 Added 8.39%
9,097 $359,000
Q3 2019

Oct 25, 2019

SELL
$32.49 - $42.13 $23,295 - $30,207
-717 Reduced 7.87%
8,393 $302,000
Q2 2019

Aug 20, 2019

SELL
$36.98 - $41.52 $4,733 - $5,314
-128 Reduced 1.39%
9,110 $395,000
Q1 2019

Apr 18, 2019

BUY
$37.5 - $41.2 $346,425 - $380,605
9,238 New
9,238 $392,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sage Rhino Capital LLC Portfolio

Follow Sage Rhino Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.